Chemoselective Reduction of Conjugated Indole-maleimides and Oxindole-esters via Zn/TiCl₄-Assisted Unified Approach
Synlett · 01.03.2026 · 37 (04) · 555-560
DOI: 10.1055/a-2752-8022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 01.03.2026. Verfasst von Supriya Sharma und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
Chemoselective reduction of electron-deficient alkenes incorporated within structurally diverse heterocyclic frameworks, such as indole-tethered maleimide and oxindole-based unsaturated esters, is disclosed using a Zn/TiCl₄-catalyzed quick protocol (0 °C, 10 min). The reducing agent Zn/TiCl₄ offers a non-hydrogenative, metal-economical strategy that demonstrates excellent chemoselectivity and suggests potential applicability toward late-stage functionalization. The protocol exhibited broad substrate scope (32 examples), providing a route to access saturated analogs in excellent yields up to 95% and tolerance to other functional moieties: esters and amides.
Förderung
- Science and Engineering Research Board
Zitieren
APA
Sharma, S., Chauhan, A. N. S., Gajare, S. D., Kumar, A., & Erande, R. D. (2026). Chemoselective Reduction of Conjugated Indole-maleimides and Oxindole-esters via Zn/TiCl₄-Assisted Unified Approach. Synlett, 37(04), 555-560. https://doi.org/10.1055/a-2752-8022
Vancouver
Sharma S, Chauhan ANS, Gajare SD, Kumar A, Erande RD. Chemoselective Reduction of Conjugated Indole-maleimides and Oxindole-esters via Zn/TiCl₄-Assisted Unified Approach. Synlett. 2026;37(04):555-560. doi:10.1055/a-2752-8022
BibTeX
@article{Sharma2026,
author = {Sharma, Supriya and Chauhan, Amar Nath Singh and Gajare, Swaranjali D. and Kumar, Akhilesh and Erande, Rohan D.},
title = {Chemoselective Reduction of Conjugated Indole-maleimides and Oxindole-esters via Zn/TiCl₄-Assisted Unified Approach},
journal = {Synlett},
year = {2026},
volume = {37},
number = {04},
pages = {555--560},
doi = {10.1055/a-2752-8022}
}
EUVIMED